Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanced BioPhotonics enters trial agreement with Beth Israel Deaconess:

This article was originally published in Clinica

Executive Summary

Imaging firm Advanced BioPhotonics has entered into a pilot research agreement with the Beth Israel Deaconess Medical Center (BIDMC) - a teaching hospital of Harvard Medical School. As part of the agreement, BIDMC will be carrying out a clinical trial of the company's patented BioScanIR system, which it says provides a fast, noninvasive, radiation-free method for detecting diseases that affect perfusion and reperfusion in human tissue. The first phase of the trial is scheduled to begin in September 2007, said the Bohemia, New York-based company. The BioScanIR system uses the firm's proprietary DIRI - dynamic infrared imaging - technology, which has been developed for detecting and assessing pigmented lesions of the skin including melanoma and other forms of skin cancer.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel